Mr. Speaker, I can assure the hon. member that I have no interest in lobbyists' efforts. What I care about the most is Canadians' interests.
We promised during the election campaign that we would review Bill C-91, and that is what we explained again yesterday. We are interested in drug prices and in the investment and R and D track record here in Canada.